SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001295947-11-000019
Filing Date
2011-08-04
Accepted
2011-08-04 08:00:51
Documents
23
Period of Report
2011-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8-kpressreleaseaug22011.htm 8-K 50508
2 PRESS RELEASE DATED AUGUST 4, 2011 fy12-q1earningsreleaseexhi.htm EX-99.1 354540
3 INVESTOR RELATIONS SLIDESHOW a992investorrelationsslidesh.htm EX-99.2 14348
4 q112investorpresenta0001.jpg GRAPHIC 114960
5 q112investorpresenta0002.jpg GRAPHIC 235383
6 q112investorpresenta0003.jpg GRAPHIC 118638
7 q112investorpresenta0004.jpg GRAPHIC 62754
8 q112investorpresenta0005.jpg GRAPHIC 93006
9 q112investorpresenta0006.jpg GRAPHIC 66447
10 q112investorpresenta0007.jpg GRAPHIC 60923
11 q112investorpresenta0008.jpg GRAPHIC 102819
12 q112investorpresenta0009.jpg GRAPHIC 79770
13 q112investorpresenta0010.jpg GRAPHIC 113266
14 q112investorpresenta0011.jpg GRAPHIC 121510
15 q112investorpresenta0012.jpg GRAPHIC 146127
16 q112investorpresenta0013.jpg GRAPHIC 109390
17 q112investorpresenta0014.jpg GRAPHIC 159465
18 q112investorpresenta0015.jpg GRAPHIC 78319
19 q112investorpresenta0016.jpg GRAPHIC 140185
20 q112investorpresenta0017.jpg GRAPHIC 99943
21 q112investorpresenta0018.jpg GRAPHIC 64597
22 q112investorpresenta0019.jpg GRAPHIC 70551
23 99.2 INVESTOR RELATIONS SLIDESHOW q112investorpresenta0020.jpg GRAPHIC 94647
  Complete submission text file 0001295947-11-000019.txt   3362130
Mailing Address 90 NORTH BROADWAY IRVINGTON NY 10533
Business Address 90 NORTH BROADWAY IRVINGTON NY 10533 (914) 524-6810
Prestige Brands Holdings, Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0902
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 111008713
SIC: 2834 Pharmaceutical Preparations